361 related articles for article (PubMed ID: 28777385)
1. Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye.
Postorino EI; Rania L; Aragona E; Mannucci C; Alibrandi A; Calapai G; Puzzolo D; Aragona P
Eur J Ophthalmol; 2018 Jan; 28(1):25-31. PubMed ID: 28777385
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of eye drops containing crosslinked hyaluronic acid and CoQ10 in restoring ocular health exposed to chlorinated water.
Tredici C; Fasciani R; Villano A; Gambini G; Caporossi A
Eur J Ophthalmol; 2020 May; 30(3):430-438. PubMed ID: 32064920
[TBL] [Abstract][Full Text] [Related]
3. Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.
Johnson ME; Murphy PJ; Boulton M
Optom Vis Sci; 2008 Aug; 85(8):750-7. PubMed ID: 18677239
[TBL] [Abstract][Full Text] [Related]
4. The effect of an artificial tear combining hyaluronic acid and tamarind seeds polysaccharide in patients with moderate dry eye syndrome: a new treatment for dry eye.
Barabino S; Rolando M; Nardi M; Bonini S; Aragona P; Traverso CE
Eur J Ophthalmol; 2014; 24(2):173-8. PubMed ID: 24030535
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease.
Lee JH; Ahn HS; Kim EK; Kim TI
Cornea; 2011 Feb; 30(2):175-9. PubMed ID: 21045674
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time.
Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC
J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of 0.1% crosslinked hyaluronic acid, coenzyme Q10 and vitamin E in the management of dry eye disease in menopause patients receiving antidepressants.
Serrano-Morales JM; De-Hita-Cantalejo C; Sánchez-González MC; Bautista-Llamas MJ; Sánchez-González JM
Eur J Ophthalmol; 2022 Jan; 32(1):658-663. PubMed ID: 33153310
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC
Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of an Artificial Tear Containing 0.3% Hyaluronic Acid in the Management of Moderate-to-Severe Dry Eye Disease.
López-de la Rosa A; Pinto-Fraga J; Blázquez Arauzo F; Urbano Rodríguez R; González-García MJ
Eye Contact Lens; 2017 Nov; 43(6):383-388. PubMed ID: 27243353
[TBL] [Abstract][Full Text] [Related]
10. Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye.
Labetoulle M; Chiambaretta F; Shirlaw A; Leaback R; Baudouin C
Eye (Lond); 2017 Oct; 31(10):1409-1416. PubMed ID: 28452989
[TBL] [Abstract][Full Text] [Related]
11. Combining Sodium Hyaluronate and Polyvinylpyrrolidone Therapies for the Rabbit Cornea: A New Approach to Relief of the Human Dry Eye Syndrome.
Ehrenberg M; Zolotariov E; Loeb E; Poliansky V; Levy A
Curr Eye Res; 2015 Sep; 40(9):913-22. PubMed ID: 25329624
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of Lifitegrast 5% Ophthalmic Solution in the Treatment of Dry Eye Disease.
Tong AY; Passi SF; Gupta PK
Eye Contact Lens; 2020 Jan; 46 Suppl 1():S20-S24. PubMed ID: 30985492
[TBL] [Abstract][Full Text] [Related]
13. Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensive Therapy.
Roberti G; Agnifili L; Berardo F; Riva I; Figus M; Manni G; Quaranta L; Oddone F
Adv Ther; 2018 May; 35(5):686-696. PubMed ID: 29687335
[TBL] [Abstract][Full Text] [Related]
14. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
Tauber J; Karpecki P; Latkany R; Luchs J; Martel J; Sall K; Raychaudhuri A; Smith V; Semba CP;
Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Cortisol Phosphate in Hyaluronic Acid Vehicle in the Treatment of Dry Eye in Sjogren Syndrome.
Rolando M; Vagge A
J Ocul Pharmacol Ther; 2017 Jun; 33(5):383-390. PubMed ID: 28375792
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
Lee HS; Ji YS; Yoon KC
Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
[TBL] [Abstract][Full Text] [Related]
17. Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease--A Prospective, Multicenter Noninterventional Study.
Steven P; Scherer D; Krösser S; Beckert M; Cursiefen C; Kaercher T
J Ocul Pharmacol Ther; 2015 Oct; 31(8):498-503. PubMed ID: 26296040
[TBL] [Abstract][Full Text] [Related]
18. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye.
Li Z; Choi JH; Oh HJ; Park SH; Lee JB; Yoon KC
Curr Eye Res; 2014 Sep; 39(9):871-8. PubMed ID: 24559509
[TBL] [Abstract][Full Text] [Related]
19. Effects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapy.
Monaco G; Cacioppo V; Consonni D; Troiano P
Eur J Ophthalmol; 2011; 21(3):243-50. PubMed ID: 20872359
[TBL] [Abstract][Full Text] [Related]
20. Dry eye and inflammation of the ocular surface after cataract surgery: effectiveness of a tear film substitute based on trehalose/hyaluronic acid vs hyaluronic acid to resolve signs and symptoms.
Cagini C; Di Lascio G; Torroni G; Mariniello M; Meschini G; Lupidi M; Messina M
J Cataract Refract Surg; 2021 Nov; 47(11):1430-1435. PubMed ID: 34675150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
